Q
36.12
0.52 (1.46%)
| Penutupan Terdahulu | 35.60 |
| Buka | 35.82 |
| Jumlah Dagangan | 677,530 |
| Purata Dagangan (3B) | 868,318 |
| Modal Pasaran | 2,436,167,424 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.27 |
| Harga / Jualan (P/S) | 0.680 |
| Harga / Buku (P/B) | 0.630 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2025 - 11 May 2025 |
| Margin Keuntungan | -73.74% |
| Margin Operasi (TTM) | 6.64% |
| EPS Cair (TTM) | -30.54 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 89.84% |
| Nisbah Semasa (MRQ) | 1.22 |
| Aliran Tunai Operasi (OCF TTM) | 83.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 211.81 M |
| Pulangan Atas Aset (ROA TTM) | 0.65% |
| Pulangan Atas Ekuiti (ROE TTM) | -51.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | QuidelOrtho Corporation | Menaik | Menurun |
AISkor Stockmoo
1.1
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 1.10 |
|
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.43% |
| % Dimiliki oleh Institusi | 109.35% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 61.00 (RBC Capital, 68.88%) | Beli |
| Median | 53.00 (46.73%) | |
| Rendah | 45.00 (UBS, 24.59%) | Pegang |
| Purata | 53.00 (46.73%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 41.65 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| RBC Capital | 13 Feb 2025 | 61.00 (68.88%) | Beli | 41.65 |
| UBS | 13 Feb 2025 | 45.00 (24.58%) | Pegang | 41.65 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BUSKY JOSEPH M. | 34.89 | 34.89 | 3,323 | 115,939 |
| HODGES MICHELLE A | 34.89 | 34.89 | 1,581 | 55,161 |
| Jumlah Keseluruhan Kuantiti Bersih | 4,904 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 171,101 | |||
| Purata Pembelian Keseluruhan ($) | 34.89 | |||
| Purata Jualan Keseluruhan ($) | 34.89 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HODGES MICHELLE A | Pegawai | 28 Mar 2025 | Diperolehi (+) | 2,463 | 34.89 | 85,934 |
| HODGES MICHELLE A | Pegawai | 28 Mar 2025 | Dibuang (-) | 882 | 34.89 | 30,773 |
| BUSKY JOSEPH M. | Pegawai | 28 Mar 2025 | Diperolehi (+) | 4,925 | 34.89 | 171,833 |
| BUSKY JOSEPH M. | Pegawai | 28 Mar 2025 | Dibuang (-) | 1,602 | 34.89 | 55,894 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Mar 2025 | Pengumuman | QuidelOrtho® Introduces Results Manager™ System |
| 24 Feb 2025 | Pengumuman | QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference |
| 12 Feb 2025 | Pengumuman | QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results |
| 13 Jan 2025 | Pengumuman | QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |